Budget Amount *help |
¥16,770,000 (Direct Cost: ¥12,900,000、Indirect Cost: ¥3,870,000)
Fiscal Year 2020: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2019: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2018: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2017: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
|
Outline of Final Research Achievements |
For conquest of intractable lung disease due to lifestyle, pulmonary drug delivery system (DDS) for the lesion detection and treatment of these diseases was developed. In brief, the lipid nano formulations for pulmonary administration were prepared for inspection and treatment of lung cancer and pulmonary fibrosis in the near future, and their intrapulmonary behaviors, efficacy and safety were demonstrated.
|